Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest

Purpose The aim of the study was to evaluate the effects of dienogest (DNG) on quality of life (QoL) and sexual function of women affected by endometriosis pain.

Fifty-four women constituted the study group and were given 2 mg/daily DNG; 48 women were given non-steroidal anti-inflammatory drugs and constitut ed the control group. To define the endometriosis-associated pelvic pain, the Visual Analogic Scale (VAS) was used. The Short Form-36 (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to assess the QoL, the sexual function and the sexual distress, respectively. The study included two follow-ups at 3 and 6 months.

Pain improvement was observed in the study group at 3 (p < 0.05) and 6 months (p < 0.001) of treatment. At the 1st follow-up, women reported QoL improvements in some functions (p < 0.05); at the 2nd follow-up, they reported improvement in all categories (p < 0.001). The FSFI score did not change at the 1st follow-up (p = NS). On the contrary, at the 2nd follow-up, it improved with respect to the baseline (p < 0.05). At the 2nd follow-up, the FSFI score had risen to 27.8 (p < 0.001) and the FSDS score had dropped to 11.3 (p < 0.001). No change was observed in the control group (p = NS).

The progressive reduction of the pain syndrome reported by women over the treatment period could contribute to improve the QoL and sexual life of women on DNG. Similar content being viewed by others

Hyun Shin JA, Howard FM (2011) Management of chronic pelvic pain. Curr Pain Headache Rep 15:377–385 Sinaii N, Plumb K, Cotton L, Lambert A, Kennedy S, Zondervan K, Stratton P (2008) Differences in characteristics of 1.000 women with endometriosis based on extent of disease. Fertil Steril 89:538–545 Rogers PA, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA, Zondervan KT (2009) Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 16:335–346 Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E, ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20:2698–2704 Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W, European Society of Human Reproduction and Embryology (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400–412 Vercellini P, Viganò P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10:261–275 Huntington A, Gilmour JA (2005) A life shaped by pain: women and endometriosis. J Clin Nurs 14:1124–1132 Denny E (2004) Women’s experience of endometriosis. J Adv Nurs 46:641–648 Nnoaham KE, Sivananthan S, Hummelshoj L, Jenkinson C, Webster P, Kennedy SH, Zondervan KT (2009) Multi-centre studies of the global impact of endometriosis and the predictive value of associated symptoms. J Endometr 1:36–45 Sepulcri RP, do Amarai VF (2009) Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 142:53–56 Hummelshoj L, De Graaff A, Dunselman G, Vercellini P (2014) Let’s talk about sex and endometriosis. J Fam Plann Reprod Health Care 40:8–10 Allen C, Hopewell S, Prentice A, Gregory D (2009) Nonsteroidal antiinflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 15(2):CD004753 The Practice Committee of the American Society for Reproductive Medicine (2014) Treatment of pelvic pain associated with endometriosis. Fertil Steril 101:927–935 Caruso S, Agnello C, Romano M, Cianci S, Lo Presti L, Malandrino C, Cianci A (2011) Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med 8:2841–2850 Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A (2015) Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive. A patient-preference prospective 24-week pilot study. Reprod Sci 2015(22):626–632 Harada T, Taniguchi F (2010) Dienogest: a new therapeutic agent for the treatment of endometriosis. Womens Health (Lond Engl) 6:27–35 Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151:193–198 Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H (2001) The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod 7:341–347 Nakamura M, Katsuki Y, Shibutani Y, Oikawa T (1999) Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis. Eur J Pharmacol 386:33–40 Exacoustos C, Manganaro L, Zupi E (2014) Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 28:655–681 Gallagher EJ, Liebman M, Bijur PE (2001) Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 38:633–638 Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplège A, Prieto L, Sullivan M (1998) The factor structure of the SF-36 Health Survey in 10 countries: Results from the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 51:1159–1165 Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, Graziottin A, Heiman JR, Laan E, Meston C, Schover L, van Lankveld J, Schultz WW (2004) Revised definitions of women’s sexual dysfunction. J Sex Med 1:40–48 Nappi RE, Albani F, Vaccaro P, Gardella B, Salonia A, Chiovato L, Spinillo A, Polatti F (2008) Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol 24:214–219 Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J (2002) The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal in distress women. J Sex Marital Ther 28:317–330 Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S (2014) Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur J Obstet Gynecol Reprod Biol 183:188–192 Nappi RE, Serrani M, Jensen JT (2014) Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. Int J Womens Health. 6:711–718 Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A (2015) Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study. Reprod Sci 22:626–632 Miyashita M, Koga K, Takamura M et al (2014) Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecol Endocrinol 30:644–648 Stein SL (2013) Chronic pelvic pain. Gastroenterol Clin North Am 42:785–800 Nnoaham KE, Hummelshoj L,Webster P, d’Hooghe T, de Cicco Nardone F,de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT, World Endometriosis Research Foundation Global Study of Women’s Health consortium (2011) Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 96:366–373 Laufer MR (2008) Current approaches to optimizing the treatment of endometriosis in adolescents. Gynecol Obstet Invest 66(Suppl 1):19–27 Foster RH, Wild MI (1998) Dienogest. Drugs 56:825–833 Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C (2010) Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 25:633–641 Vercellini P, Frattaruolo MP, Somigliana E, Jones GL, Consonni D, Alberico D, Fedele L (2013) Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 28:1221–1230 Triunfo S, Lanzone A (2015) Potential impact of maternal vitamin D status on obstetric well-being. J Endocrinol Invest (Epub ahead of print) Acknowledgments The authors wish to thank The Scientific Bureau of the University of Catania, Italy, for language support. Author information Authors and Affiliations Corresponding author Ethics declarations Conflict of interest None. Ethical approval I declare that this study was approved by the Institutional Review Board (IRB) of our Department. Informed consent Informed consent was obtained from all individual participants included in the study. Rights and permissions About this article Cite this article Caruso, S., Iraci, M., Cianci, S. et al. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest. J Endocrinol Invest 38, 1211–1218 (2015). https://doi.org/10.1007/s40618-015-0383-7 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s40618-015-0383-7